CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (31)
2022
-
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
Frontiers in immunology, Vol. 13, pp. 842354
-
Consensus on early detection of disease progression in patients with multiple sclerosis
Frontiers in Neurology, Vol. 13
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 59
2021
-
Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment
Multiple Sclerosis and Related Disorders, Vol. 49
-
Risk and outcomes of COVID-19 in patients with multiple sclerosis
European Journal of Neurology, Vol. 28, Núm. 11, pp. 3712-3721
2020
-
Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study
CNS Drugs, Vol. 34, Núm. 12, pp. 1275-1286
-
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population
Journal of Neurology, Vol. 267, Núm. 8, pp. 2362-2371
2019
-
Recomendaciones de uso de cladribina comprimidos en la esclerosis múltiple recurrente
Revista de neurologia, Vol. 69, Núm. s02, pp. 1-9
-
Review of the novelties presented at the 2018 ECTRIMS congress: 11th post-ECTRIMS meeting (II)
Revista de Neurologia, Vol. 68, Núm. 11, pp. 468-479
-
Review of the novelties presented at the 2018 ectrims congress: 11th post-ectrims meeting (I)
Revista de Neurologia, Vol. 68, Núm. 10, pp. 431-441
2017
-
Revisión de las novedades del XXXII Congreso ECTRIMS 2016, presentadas en la IX Reunión Post-ECTRIMS (II)
Revista de Neurologia, Vol. 65, Núm. 2, pp. 75-84
-
Revisión de las novedades del XXXII congreso ectrims 2016, presentadas en la ix reunión post-ectrims (I)
Revista de Neurologia, Vol. 65, Núm. 1, pp. 31-40
2016
-
Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS
Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569
2015
-
Consenso español actualizado sobre el uso del natalizumab (Tysabri®)-2013
Neurologia, Vol. 30, Núm. 5, pp. 302-314
-
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e147
-
Review of the novelties from the 2014 ECTRIMS-ACTRIMS joint congress, presented at the 7th post-ECTRIMS meeting (II)
Revista de Neurologia, Vol. 61, Núm. 6, pp. 271-283
-
Review of the novelties from the 2014 ectrims-actrims joint congress, presented at the 7th post-ectrims meeting (i)
Revista de Neurologia, Vol. 61, Núm. 5, pp. 215-224
2014
-
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)
Revista de Neurologia, Vol. 59, Núm. 7, pp. 307-316
-
Revisión de las novedades presentadas en el XXIX congreso del comité Europeo para el tratamiento e investigación en esclerosis múltiple (ECTRIMS) (III)
Revista de Neurologia, Vol. 59, Núm. 8, pp. 371-379